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Abstract
After infection with Borrelia species, the risk for developing Lyme disease varies significantly between individuals.
Recognition of Borrelia by the immune system is mediated by pattern recognition receptors (PRRs), such as TLRs. While TLR2
is the main recognition receptor for Borrelia spp., little is known about the role of TLR1 and TLR6, which both can form
functionally active heterodimers with TLR2. Here we investigated the recognition of Borrelia by both murine and human
TLR1 and TLR6. Peritoneal macrophages from TLR1- and TLR6- gene deficient mice were isolated and exposed to Borrelia.
Human PBMCs were stimulated with Borrelia with or without specific TLR1 and TLR6 blocking using specific antibodies.
Finally, the functional consequences of TLR polymorphisms on Borrelia-induced cytokine production were assessed.
Splenocytes isolated from both TLR12/2 and TLR62/2 mice displayed a distorted Th1/Th2 cytokine balance after
stimulation with B.burgdorferi, while no differences in pro-inflammatory cytokine production were observed. In contrast,
blockade of TLR1 with specific neutralizing antibodies led to decreased cytokine production by human PBMCs after
exposure to B.burgdorferi. Blockade of human TLR6 did not lead to suppression of cytokine production. When PBMCs from
healthy individuals bearing polymorphisms in TLR1 were exposed to B.burgdorferi, a remarkably decreased in vitro cytokine
production was observed in comparison to wild-type controls. TLR6 polymorphisms lead to a minor modified cytokine
production. This study indicates a dominant role for TLR1/TLR2 heterodimers in the induction of the early inflammatory
response by Borrelia spirochetes in humans.
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Introduction
Ticks of the Ixodes family are able to transmit bacteria of the
Borrelia burgdorferi sensu lato family, which causes Lyme Disease [1].
Within this family, three species are described to be pathogenic,
namely B.burgdorferi sensu stricto, B.afzelii, and B.garinii, which are
differentially distributed between the United States and Europe.
Clinical signs that develop after infection with Borrelia spirochetes
are diverse, ranging from skin abnormalities (erythema migrans) to
arthritis or carditis [2]. Infection with Borrelia results in release of
inflammatory mediators and recruitment of inflammatory cells to
the site of infection [3,4]. To induce inflammation, recognition of
the bacteria by pattern recognition receptors (PRRs) is necessary.
Distinct classes of PRRs have been described, including C-type
lectins (CLRs), NOD-like receptors (NLRs), and Toll-like
receptors (TLRs). TLR4, the main receptor for bacterial
lipopolysaccharides [5], has been shown not to be involved in
the recognition of Borrelia [6]. On the other hand, TLR2 plays an
important role in the recognition of Borrelia components. It has
been demonstrated that TLR2-knockout mice produced signifi-
cantly lower concentrations of antibodies against Borrelia after
immunization with OspA [7]. TLR2 knockout mice harbor higher
amounts of Borrelia spirochetes at the site of inflammation than
wild-type animals and hence exhibit more cell influx in infected
joints [8,9]. In humans, TLR2 can recognize several components
of Borrelia [10,11], and TLR2 blockade in human peripheral blood
mononuclear cells (PBMCs) resulted in decreased cytokine
production after exposure to intact Borrelia spirochetes [6]. In
order to recognize its ligands, TLR2 forms heterodimers with
other members of the TLR family (TLR1 or TLR6) [12]. TLR1/
TLR2 heterodimers recognize mainly triacylated lipopeptides,
whereas TLR2/TLR6 heterodimers recognize diacylated lipopep-
tides [13,14]. TLR1/2 heterodimers induce also a different
immune response against pathogens as compared to TLR2/6
heterodimers [15,16]. When TLR1/2 molecules are absent, less
induction of early cytokines were observed, whereas TLR2/6
seems able to modulate the balance between a Th1/Th2 immune
response.
Limited information is available about recognition of B.
burgdorferi by TLR1 and TLR6 in murine and human cell systems,
and the relative contribution of these receptors as components of
the heterodimers with TLR2 for the recognition of Borrelia species
has not been elucidated for primary cells [7,17–20]. In addition,
mutations in TLR1 and TLR6 receptors are associated with
differential susceptibility to bacterial and fungal infections [15,21],
and the question arises to what extent these polymorphisms may
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lead to changes in production of cytokines after exposure to Borrelia
species, and hence might influence the clinical outcome of Lyme
disease. Thus, we investigated the role of TLR1 and TLR6 in the
recognition of Borrelia species by mouse cells and primary human
cells, and assessed whether polymorphisms in either the TLR1 or
the TLR6 gene influence the cytokine responses. We observed an
important role for TLR1/2 heterodimers for the recognition of
Borrelia species and for the induction of an early immune response
against Borrelia spirochetes in humans.
Results
TLR1 activation enhanced the induction of IFN-c by
murine splenocytes after exposure to B. burgdorferi
Peritoneal macrophages from TLR1 knockout animals pro-
duced the same amounts of pro-inflammatory cytokines IL-1b, IL-
6, and TNF-a, as compared to cells isolated from wild-type
C57Bl/6 mice (Figure 1A–C). However, a significant decrease in
IL-10 production could be observed when TLR1-deficient
splenocytes were stimulated with B. burgdorferi for 5 days
(Figure 1D). Moreover, IFN-c production induced by B. burgdorferi
in TLR1-deficient splenocytes was significantly higher than in
controls (Figure 1E). Finally, IL-17 production was somewhat
higher after stimulation of TLR1 knockout cells, but not found to
be statistically significant (Figure 1F).
Borrelia-induced IFN-c production by murine cells is
dependent on TLR6
To assess the role of TLR6, 16106 live Borrelia burgdorferi
spirochetes were added to freshly isolated peritoneal macrophages
of either wild-type or TLR6 gene-deficient mice. After 24 hours of
stimulation, no differences in the production of pro-inflammatory
cytokines IL-1b, IL-6, and TNF-a could be detected between cells
isolated from wild-type or TLR6 knock-out mice (Figure 2A, 2B,
and 2C, respectively). Other cytokines, such as IL-10, IL-17 and
IFN-c are known to be involved in the immune response against
Borrelia [23,24], splenocytes of wild-type or TLR6 knock-out mice
were incubated for 5 days with Borrelia. Thereafter, the production
of IL-10, IFN-c, and IL-17 was measured by ELISA (Figure 2D–
F). A significant decrease in IFN-c production was detected in
mice lacking functional TLR6. IL-10 and IL-17 production tended
to be lower in these mice, but these differences did not reach
statistically significance (Figure 2D and 2F).
Differential role of human TLR1 and TLR6 for the
recognition of Borrelia
To investigate the relative roles of TLR1 and TLR6 signalling
for the recognition of Borrelia by human primary cells, neutralizing
antibodies were used to inhibit the function of these specific TLRs.
When PBMCs from 5 healthy individuals were incubated for
24 hours with blocking anti-TLR1, anti-TLR6, anti-TLR2
antibodies, or control IgG1 antibody alone, no production of
pro-inflammatory cytokines and chemokines could be detected
(data not shown). Inhibition of cytokines produced upon Pam3Cys
stimulation could only be observed when using the anti-TLR1
antibody and could not be inhibited by TLR6 antibodies (not
shown). When human PBMCs were incubated with B. burgdorferi in
the presence of a specific anti-TLR1 antibody, a significant
reduction in IL-1b, IL-6 (but not TNFa), and chemokine IL-8
production was observed (Figure 3A-D). In contrast to TLR1,
human TLR6 seems to play a minor role in the induction of pro-
inflammatory cytokines after Borrelia stimulation of PBMCs.
Production of IL-6, IL-1b, or IL-8 was not significantly inhibited
after a neutralizing TLR6 antibody was added to the cultures
(Figure 3A-D). As demonstrated previously, TLR2 is important for
the induction of cytokine responses by Borrelia in human PBMCs
(Figure 3A-D). No significant differences in cytokine production
could be observed when Borrelia was co-incubated with IgG
antibody alone (Figure 3A–D).
The role of human TLR1 polymorphisms in cytokine
production by B. burgdorferi
PBMCs isolated from individuals carrying different TLR1
genotypes were incubated for 24 hours with Borrelia, or the TLR2
specific ligand Pam3Cys. Cytokine production was significantly
lower after stimulation of PBMCs with Pam3Cys in cells isolated
from individuals homozygous for the R80T, N248S, and S602I
polymorphisms in TLR1 (Figure 4). For the TLR1 R80T
polymorphism, we observed a trend towards lower production of
IL-1b after PBMC stimulation with 16106 B. burgdorferi microor-
ganisms per mL (Figure 4A). These results are in line with previous
reports showing that the presence of the TLR1 polymorphisms
R80T, N248S and S602I led to decreased signaling and cytokine
production after Pam3Cys stimulation [23–26]. A significantly
decreased IL-1b production after Borrelia exposure could be
detected in persons heterozygous or homozygous for the TLR1
polymorphism N248S or S602I (Figure 4B and 4C). Significant
differences between the wild-type, heterozygous, and homozygous
carriers of the TLR1 SNPs were found with respect to IL-6, IL-8,
TNF-a, and IL-10 production, after incubation of their PBMCs
with Borrelia or Pam3Cys (Supplementary tables S1, S2, and S3).
Human TLR6 polymorphisms are less involved in
cytokine induction after stimulation with B. burgdorferi
The non-synonymous polymorphism S249P in the TLR6 gene,
believed to result in a malfunction in the extracellular domain of
the TLR6 molecule, is present with a high frequency in several
different populations (.10%) [27]. However, after PBMC
stimulation for 24 h with the specific TLR2/6 ligand FSL-1, we
did not detect differences between individuals with or without the
TLR6 polymorphism in either IL-1b, IL-6, IL-8, IL-10, or TNF-a
(Figure 5A-E, respectively). On the other hand, we could observe
lower IL-1b, IL-6, and IL-8 production by cells of individuals
bearing the S249P SNP after stimulation with Borrelia burgdorferi.
Human TLR1 is involved in Borrelia-induced IFN-c
Since we demonstrated that TLR1 controls the induction of IFN-
c in mice, we assessed whether TLR1 is involved in human IFN-c
and IL-17 responses upon encounter of Borrelia species. PBMCs
isolated from healthy volunteers bearing either a TLR1 or TLR6
polymorphism were stimulated for 7 days with either medium, live
Borrelia, or Pam3Cys. Pam3Cys-induced IFN-c was less produced
by cells isolated from individuals bearing TLR1 SNPs, but no
differences could be observed for cells with the described TLR6
SNP (data not shown). IFN-c levels after Borrelia stimulation were
significantly decreased in individuals lacking a functional TLR1
molecule, whereas TLR6 seems not to play a major role in the
induction of this pro-inflammatory cytokine (Fig. 6A-B, respective-
ly). TLR1 might also play a role in the induction of IL-17 after
Borrelia exposure, a trend towards lower production could be
detected, although not found to be significant (Fig.6C). TLR6 seems
not involved in Borrelia-induced IL-17 production (Fig.6D).
Discussion
The present study expands the knowledge regarding the role of
both TLR1/2 and TLR2/6 heterodimers in the recognition of
Borrelia Recognition TLR1/TLR2
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Borrelia spp. We demonstrate that TLR1 in humans is an important
component for the recognition and induction of an immune
response against Borrelia. This was demonstrated by experiments
using either TLR1- or TLR6 deficient murine cells, as well as
studies performed in cells isolated from individuals bearing genetic
polymorphisms in TLR1 or TLR6. Of high interest, a different
pattern was found in murine cells; genetic disruption of TLR1
resulted in an upregulated IFN-c response, whereas TLR6 deficient
cells were unable to induce a sufficient IFN-c response after Borrelia
exposure. This difference in IFN-c induction in mice between
TLR1 or TLR6 could not be observed in humans. Neither TLR1
and TLR6 seem to be involved in the induction of this cytokine
upon stimulation with Borrelia spirochetes.
TLR1/2 or TLR2/6 heterodimers do not only differ in
structure, but also recognize different ligands. Whereas TLR1/2
heterodimers mainly recognize tri-acetylated structures such as
Pam3Cys, di-acetylated proteins are mainly recognized by TLR2/
6 heterodimers [13,14]. It is known that Borrelia spp. contains tri-
acetylated proteins in the cell membrane and this fits with our
observation that the TLR1 containing heterodimers are more
important in recognition and signaling of Borrelia.
The genome of Borrelia burgdorferi encodes at least 105
membrane proteins, including the group of immunologically
important outer surface proteins (OSPs) [28]. It has been
suggested that Borrelia outer surface protein A (OspA) plays an
important role in the pathogenesis of Lyme disease caused by
Figure 1. In vitro cytokine production by TLR12/2 cells after stimulation with Borrelia. 16105 peritoneal macrophages from five C57Bl/6
mice were stimulated separately for 24 hours with 16106 live B.burgdorferi per mL. Levels of IL-1b (A), IL-6 (B), and TNF-a (C) were measured in the
supernatants and compared to the cytokine production induced by cells deficient in expressing TLR1 (black bars, represent TLR12/2 cytokine
responses). Spleen cells (56106/well) of both wild-type (black bars) and TLR12/2 (white bars) mice were stimulated for 5 days with 16106 live
Borrelia per mL and levels of IL-10, IFN-c, and IL-17 were measured in the supernatant using ELISA (D–F, respectively). Bars represent the mean6 SEM
of 5 animals per group. **p,0.01 (for comparisons between wild-type and knock-out mice), Mann-Whitney U-test, experiments were performed in
duplicates.
doi:10.1371/journal.pone.0025998.g001
Borrelia Recognition TLR1/TLR2
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Borrelia species. Macrophages isolated from TLR1 deficient mice
display an impaired ability to induce IL-6 after stimulation with
OspA lipoprotein [7]. In contrast to these studies, we were unable
to detect any differences in IL-6 production between wild-type and
TLR1 knockout mice, when cells were stimulated with intact
Borrelia spirochetes. This effect might be due to the presence of
multiple ligands that are absent in studies that use solely purified
OspA protein in supraphysiological concentrations. Using intact
bacteria, the immune response is likely stimulated through several
distinct PRR pathways, involving both TLRs and NODs [6].
Disruption of either the TLR1 or TLR6 gene in mice did not
lead to changes in the pro-inflammatory cytokine production, with
the exception of the T-cell-derived IFN-c and IL-17. This implies
that in the mouse the intact TLR1/TLR2 heterodimers dampen
the interferon gamma response. This effect may be mediated
through IL-10, since this cytokine was downregulated in mice
lacking functional TLR1 molecules. It may be hypothesized that
murine TLR1 and TLR6 exert counter-regulatory roles for the
induction of Th1/Th17 cytokines by Borrelia bacteria.
Mutations in TLR1 can lead to a decreased surface protein
expression of TLR1 on the cell surface and diminished activation of
NF- B [25,26]. It has been previously suggested that defects in
TLR1 signaling might play a role in the early induction of the
immune response in mice against Borrelia spp [7]. As genetic variants
have been reported to modify the function of TLRs and influence
susceptibility to infections in humans, we assessed the role of three
SNPs in TLR1 and one SNP in TLR6 for their role in the induction
of cytokines after recognition of Borrelia [21,26]. SNPs in TLR1
Figure 2. Recognition of Borrelia species by immune cells of TLR62/2 mice. Peritoneal macrophages (16105/well) of C57Bl/6 wild-type or
TLR6 gene deficient mice (n = 5 per group) were stimulated for 24 hours with 16106 live Borrelia per mL. Using ELISA or RIA, IL-1b (A), IL-6 (B), or TNF-
a (C) levels were measured in pg/mL. 56106 spleen cells/well were stimulated with 16106 live Borrelia per mL. IL-10, IFN-c, and IL-17 levels were
determined in the supernatant of 5-days spleen cell culture (D–F, respectively). White bars represent cytokine induction after stimulation of wild-type
cells, black bars the TLR6 knockout cells. An asterisk indicates that the P-value is ,0.05 (for comparisons between wild-type and knock-out mice), 5
animals per group, Mann-Whitney U-test. Bars represent the mean 6 SEM, experiments were performed in duplicates.
doi:10.1371/journal.pone.0025998.g002
Borrelia Recognition TLR1/TLR2
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e25998
impair intracellular trafficking of the TLR1, which eventually leads
to a decreased NF- B signaling. It was described before that
intracellular interactions between TLR1 and TLR2 are necessary
for optimal immune signaling in human cells [29]. A different
pattern of TLR involvement could be observed in peripheral blood
mononuclear cells isolated from humans in comparison to the
cytokines induced by mouse cells. Using cells of individuals with
functional genetic polymorphisms in the TLR1 gene, we found a
marked inhibition of the pro-inflammatory cytokine production
when these cells were exposed to Borrelia. This was found in
individuals carrying the polymorphism in both alleles (homozygous)
for any of the three SNPs in TLR1 studied. In agreement with our
data, Johnson et al exposed human monocytes with the S602I SNP
in the TLR1 gene to TLR1/TLR2 agonists and also observed an
blunted pro-inflammatory response [26].
In a recent report, the S602I SNP in TLR1 was linked to the
N248S SNP in this gene [25]; also in our study these two SNPs
displayed an 80% linkage. However, no linkage was observed with
the third SNP in TLR1 (R80T). SNP N248S and R80T have
previously been associated with invasive aspergillosis [21], and our
finding of modulation of cytokines when cells with these genetic
variations are stimulated with B. burgdorferi warrants studies of these
polymorphisms in patients with Lyme disease.
The presence of the TLR6 S249N SNP did also influence IL-
1b, IL-6, and IL-8 production induced by B. burgdorferi. TNF-a
and IL-10 levels induced by Borrelia were not changed in the
presence of the SNP. However, it did not influence cytokine
responses induced by TLR6/2 ligand FSL-1. Until now, the
precise function of this SNP is still unknown, although it has been
negatively correlated with ulcerative colitis and the development of
clinical signs of malaria, and probably offers protection against the
development of asthma [27,30,31].
These genetic findings are in agreement with those we obtained
in cultures in which human PBMCs were exposed to antibodies
against TLR1 or TLR6. In these experiments we found that
TLR6 had only a marginal effect on cytokine production (some
effect on TNF-a production), whereas TLR1 clearly mediates
Borrelia-induced cytokine production. TLR1 is also responsible for
T-cell derived cytokines after recognition of Borrelia. We observed
decreased IFN-c and IL-17 production when TLR1 molecules
were dysfunctional through the presence of polymorphisms.
In conclusion, the present study demonstrates an important role for
TLR1/TLR2 heterodimers for the recognition of Borrelia in humans.
Furthermore, the presence of genetic variants of TLR1 gene leads to
impaired cytokine responses upon challenge of PBMCs with Borrelia.
On the one hand, since initiation of host defense responses against
Figure 3. Borrelia is recognized by human TLR1 and TLR2. (A) Peripheral blood mononuclear cells (PBMCs, 56105/well) from 6 healthy
volunteers were stimulated for 24 h with 16106 B.burgdorferi per mL (grey bars). IL-6 production in the supernatant was measured using ELISA and
showed in % where Borrelia induced cytokine production is set as 100% cytokine induction. Bars represent the means 6 SEM. **p,0.01; ***p,0.001
(Mann-Whitney). Borrelia IL-6 production 100% was 3027168607 pg/mL. Anti-TLR1, 10 mg/mL specific antibody; anti-TLR6, 10 mg/mL specific
antibody; anti-TLR2, 10 mg/mL specific antibody; control IgG, mouse IgG1 isotype control 10 mg/mL. (B) IL-1b production measured in supernatant
after 24 hours culture of PBMCs stimulated with or without 16105 B.burgdorferi per mL or in the presence or absence of 10 mg/mL antibody. Borrelia
IL-1b production 100% was 5766295 pg/mL. (C) IL-8 production. Borrelia IL-8 production 100% was 121633 ng/mL (D) TNF-a production after
24 hours of stimulation. Borrelia TNF-a production 100% was 652862716 pg/mL Bars represent the means 6 standard error of the means; *p,0.05;
**p,0.01; ***p,0.001, Mann-Whitney U-test. The data shown are from three independent experiments each performed in duplicate.
doi:10.1371/journal.pone.0025998.g003
Borrelia Recognition TLR1/TLR2
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Borrelia is dependent on multiple pattern recognition receptors, more
research is needed to elucidate the precise role of TLR1/2 in the
pathogenesis of Lyme disease. On the other hand, these results give
novel information regarding the mechanisms of Borrelia recognition
and the role of TLR1 in this process, and warrants future studies in
the role of this receptor for the susceptibility to Lyme disease.
Materials and Methods
Borrelia burgdorferi cultures
B.burgdorferi, ATCC strain 35210, was cultured at 33uC in
Barbour-Stoenner-Kelley (BSK)-H medium (Sigma-Aldrich) sup-
plemented with 6% rabbit serum. Spirochetes were grown to late-
logarithmic phase and examined for motility by dark-field
microscopy. Organisms were quantitated by fluorescence micros-
copy after mixing 10 mL aliquots of culture material with 10 mL of
an acridine orange solution and counted using a Petroff-Hauser
counting chamber. Bacteria were harvested by centrifugation of
the culture at 7000 x g for 15 min., washed twice with sterile PBS
(pH 7.4), and diluted in the specified medium to required
concentrations of 16106 spirochetes per mL. Heat-killed B.
burgdorferi were prepared by heating cultured spirochetes at 52uC
for 30 min. before dilution.
Animals
TLR12/2 and TLR62/2 mice were kindly provided by Dr.
Shizuo Akira and are fully backcrossed to C57BL/6 background
(Osaka University, Japan). C57BL/6 mice were obtained from
Charles River Wiga (Sulzfeld, Germany). Female wild-type and
knock-out mice between 8 and 14 weeks of age were used. The
mice were fed sterilized laboratory chow (Hope Farms, Woerden,
The Netherlands) and water ad libitum. The experiments were
approved by the Ethics Committee on Animal Experiments of the
Radboud University Nijmegen Medical Centre.
In-vitro cytokine production
Peritoneal macrophages were isolated by injecting 5 mL of ice-
cold sterile PBS (pH 7.4) in the peritoneal cavity. After
centrifugation and washing, cells were resuspended in Roswell
Park Memorial Institute (RPMI) 1640 containing 1 mM pyruvate,
2 mM L-glutamine and 50 mg/L gentamicin (culture medium).
Cells were counted using a Z1 Coulter Particle Counter (Beckman
Coulter, Woerden, The Netherlands) and adjusted to 16106 cells/
mL. Cells were cultured in 96-well round-bottom microtiter plates
(Costar, Corning, The Netherlands) at 16105 cells/well, in a final
volume of 200 mL. After 24 hours of incubation of cells with
different stimuli at 37uC in air and 5% CO2, the plates were
centrifuged at 1400 x g for 8 min, and the supernatant was
collected and stored at 220uC until cytokine assays were
performed.
Spleen cells were isolated by gently squeezing spleens in a sterile
200 mm filter chamber. After washing with sterile PBS and
centrifugation at 4uC (1200 rpm 5 min), cells were resuspended in
4 ml RPMI 1640 in presence of 20% FCS. Cells were counted and
concentrations were adjusted to 16107 cells/ml. Cells were
cultured in 24-wells plates (Greiner, Alphen a/d Rijn, The
Netherlands) at 56106 cells/well, in a final volume of 1000 ml.
After 5 days of incubation, supernatant was collected and stored at
280uC until cytokine assays were performed.
Study populations
Individuals in this study were foresters from the ‘Geldersch
Landschap’ and ‘Kroondomein het Loo’ in the Netherlands. In
this cohort, Lyme disease occurs as an occupational disease and
Figure 4. Functional consequences of human TLR1 SNPs in
cytokine production. Peripheral blood mononuclear cells (PBMCs)
from healthy volunteers were stimulated for 24 h with different stimuli,
including Borrelia burgdorferi (16106 spirochetes/mL), and 10 mg/mL
Pam3Cys. After stimulation, supernatants were collected, and cytokine
levels were measured by enzyme-linked immunosorbent assay. The TLR1
status of these individuals was determined before PBMC stimulation, and
they were separated into 3 groups—one group did not displayed the R80T
SNP (A), N248S SNP (B), or S602I SNP (C) in TLR1 (white bars; wt; wild-type),
one group had a heterozygous mutation (grey bars), and one group had a
homozygous mutation (black bars). Data are means 6 standard errors. IL-
1b, interleukin 1b; RPMI, Roswell Park Memorial Institute 1640 medium;
*p,0.05; **p,0.01; ***p,0.001, Mann-Whitney U-test. The data shown are
from three independent experiments each performed in duplicate.
doi:10.1371/journal.pone.0025998.g004
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hence they were invited to participate. The foresters were between
23–73 years old, and consisted of 77% males and 23% females.
Samples of venous blood of them were drawn after informed
consent was obtained. Experiments were conducted according to
the principles expressed in the Declaration of Helsinki.
Isolation of genomic DNA and single nucleotide
polymorphism analysis
DNA was isolated using the Gentra Pure Gene Blood kit
(Qiagen), in accordance with the manufacturer’s protocol for
whole blood. DNA was dissolved in a final volume of 100 mL
buffer. Polymerase chain reaction (PCR) amplification of TLR1
and TLR6 gene fragments bearing the polymorphisms R80T
(rs5743611), N248S (rs4833095), and S249P (rs5743810) were
performed using a pre-designed TaqMan H SNP genotyping assay
(Applied Biosystems) in 25 mL reactions containing 2 mL of
genomic DNA as well as primers, two specific probes (with either
VIC or FAM label) and Universal PCR 2x Master mix (Applied
Biosystems). Cycling conditions were 2 min at 50uC and 10 min at
95uC followed by 40 cycli of 95uC for 15 sec and 1 min at 60uC.
Fluorescence intensities were corrected using a post-read / pre-
read method for 1 min at 60uC before and after the amplification.
The software automatically plotted genotypes based on a two-
parameter plot with an overall success rate of more than 95%.
Figure 5. Less important role for human TLR6 in the induction of cytokines after Borrelia stimulation. Peripheral blood mononuclear
cells (PBMCs) from 128 healthy volunteers carrying the S249N SNP in TLR6 were stimulated with either medium, 16106 per mL Borrelia spirochetes, or
1 mg/mL FSL-1 for 24 h and cytokines were measured using ELISA; (interleukin 1b [IL-1b],(A); IL-6,(B); IL-8,(C); IL-10, (D); and tumor necrosis factor a
[TNF-a],(E)). Bars represent individuals carrying no SNP (wild-type, wt, white bars), heterozygous SNP carriers (he, grey bars), or homozygous variation
(ho, black bars). Data represent the mean6 SEM, *p,0.05; **p,0.01; Mann-Whitney U-test. The data shown are from three independent experiments
each performed in duplicate.
doi:10.1371/journal.pone.0025998.g005
Borrelia Recognition TLR1/TLR2
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Intermediate samples were excluded from the analysis. Conven-
tional PCR amplification of the TLR1 gene fragment containing
polymorphism S602I (rs5743618) was performed on the Icycler
(BioRad) in 50 mL reactions containing 2 mL of genomic DNA,
1,5 mM MgCl2, Taq DNA polymerase conc. 5 U/mL (Invitro-
gen), PCR buffer, 20 mM dNTP (Pharmacia), 10 mM Forward
primer 59-CTA CCC GGA AAG TTA TAG AGG AAC C, and
10 mM Reversed primer 59-TTT GGC AAT AAT TCA TTC
TTC ACC. PCR consisted of one initial denaturation phase of
95uC for 10 minutes followed by 40 cycles; each cycle consisted
out of one annealing step of 95uC for 30 seconds, one
polymerization step of 60uC for 30 seconds, and one elongation
step of 72uC for 30 seconds. Subsequently, another cycle of 72uC
for 7 minutes was performed before termination. PCR products
were sequenced with either 4 mM of primers according to the
Sanger method supported by Big Dye Terminator version 3 of
Applied Biosystems. After sequencing, samples were analyzed
using the 3730 Sequence analyzer and Chromas 2.33 software
(Technelysium).
Isolation of human peripheral blood mononuclear cells
and in-vitro cytokine production
Venous blood was drawn from the cubital vein of foresters into
10 mL ethylenediaminetetraacetic acid (EDTA) tubes (Monoject).
Peripheral blood mononuclear cells (PBMCs) were isolated
according to standard protocols, with minor modifications. The
PBMC fraction obtained by density centrifugation of blood diluted
1:1 in phosphate-buffered saline (PBS)-buffer over Ficoll-Paque
(Pharmacia Biotech). Cells were washed three times in PBS and
resuspended in RPMI 1640 (Dutch modified) supplemented with
50 mg/L gentamicin, 2 mM L-glutamin, and 1 mM pyruvate.
Cells were counted in a Coulter Counter ZH (Beckman Coulter),
and adjusted to 56106 cells/mL. Mononuclear cells (56105) in a
100 mL volume were added to round-bottom 96-wells plates
(Costar, Corning, The Netherlands) and incubated with either
100 mL of medium (negative control) or B. burgdorferi (16106
spirochetes per mL). In some experiments, PBMCs were pre-
incubated with neutralizing antibodies for 30 minutes (functional
grade anti-human Toll-like receptor 1 (10 mg/mL, eBioscience),
anti-TLR6 (10 mg/mL, BioLegend), anti-TLR2 (10 mg/mL,
eBioscience) or control antibody (mouse IgG1 , 10 mg/mL,
eBioscience)). After pre-incubation, B. burgdorferi or specific TLR
ligands were added, such as Pam3Cys or FSL-1 (10 mg/mL or
1 mg/mL, respectively). After 24 hours or 7 days (in the presence
of 10% human pool serum) supernatants were collected and stored
at 220uC until being assayed.
Cytokine measurements
Concentrations of mouse IL-1b were determined by specific
radioimmunoassay (RIA; detection limit is 20 pg/mL) [22].
Figure 6. Human TLR1 is involved in Borrelia-induced IFN-c. Peripheral blood mononuclear cells (PMBCs, 56105/ well) from individuals bearing
a SNP in TLR1 (N248S) or TLR6 (S249P) were stimulated with medium, 16106 Borrelia per mL, or Pam3Cys (10 mg/mL), in the presence of 10% human
pool serum. After 7 days of incubation, IFN-c (A, B) and IL-17 (C, D) levels were determined in the supernatant using ELISA. Bars represent individuals
carrying no SNP (wild-type, wt, white bars, n$3 for TLR1 SNPs and n$5 for TLR6 SNPs), or individuals bearing the SNP in one allele or in both alleles
(mutant, mt, black bars, n$6 for TLR1 SNPs and n$7 for TLR6 SNPs). Data represent the means 6 the standard error of the means, Mann-Whitney U
test, *p,0.05. The data shown are from three independent experiments each performed in duplicate.
doi:10.1371/journal.pone.0025998.g006
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Mouse IL-6, IL-17, IFN-c, and IL-10 concentrations were
measured by a commercial ELISA kit (Biosource, Camarillo,
CA; detection limits 16 pg/mL), according to the instructions of
the manufacturer. Concentrations of human IL-1b, IL-6, IL-17, or
IFN-c were determined in duplicates using either specific or
commercial ELISA kits (PeliKine Compact, Sanquin, Amsterdam,
or R&D Systems, Minneapolis), in accordance with the manufac-
turers’ instructions. Detection limits were 40 pg/mL, except for
IFN-c ELISA (12 pg/mL).
Ethics statement
All experiments in this study were carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health, the Dutch law on Animal experiments, and FELASA
regulations. The protocol was approved by the Ethics Committee
on Animal Experiments of the Radboud University Nijmegen
Medical Centre. All efforts were made to minimize suffering of the
animals.
All human experiments were conducted according to the
principles expressed in the Declaration of Helsinki. Before taking
blood, informed written consent of each human subject was
provided. The study was approved by the review board of the
department of Medicine of the Radboud University Nijmegen
Medical Centre.
Statistical Analysis
The data are expressed as mean 6 SEM unless mentioned
otherwise. Differences between experimental groups were tested
using the two-sided Mann-Whitney U test performed on
GraphPad Prism 4.0 software (GraphPad). P values of #0.05
were considered significant.
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